Carrick Therapeutics Presents Encouraging Clinical Data for Samuraciclib (CT7001) at the 2021 San Antonio Breast Cancer Symposium

Ads

You May Also Like

Biocartis Group NV: Results of the extraordinary shareholders’ meeting held on 11 September 2017

PRESS RELEASE: REGULATED INFORMATION11 September 2017, 17:40 CEST                                                            Results of the extraordinary shareholders' meeting ...